{"transactions":[{"id":1182853,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-04-03T01:46:27.000Z","date":"2025-03-31","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on March 31, 2026"}],"balance_after":50000,"derivative":{"exercise_price":8.58,"expiration_date":"2035-03-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-25-000516","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112225000516/ownership.xml","form_type":"4"}},{"id":1622129,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-23T11:03:06.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal installments over three years from the grant date."}],"balance_after":50000,"derivative":{"exercise_price":5.36,"exercise_date":"2025-02-20","expiration_date":"2034-02-20","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-24-000293","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112224000293/ownership.xml","form_type":"4"}},{"id":1927245,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-04T21:30:31.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest in equal instalments over three years from the grant date"}],"balance_after":50000,"derivative":{"exercise_price":8.57,"exercise_date":"2024-03-31","expiration_date":"2033-03-31","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-23-000581","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112223000581/ownership.xml","form_type":"4"}},{"id":2219256,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-29T21:10:20.000Z","date":"2022-06-27","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":10.09,"exercise_date":"2023-06-27","expiration_date":"2032-06-27","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-22-001143","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222001143/ownership.xml","form_type":"4"}},{"id":2252957,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-28T00:30:22.000Z","date":"2022-05-25","kind":"exercise","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options subject to this grant vested quarterly over a three-year period commencing on April 2, 2015."}],"balance_after":0,"derivative":{"exercise_price":0.92,"expiration_date":"2025-04-02","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-22-001013","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222001013/ownership.xml","form_type":"4"}},{"id":2252956,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-28T00:30:22.000Z","date":"2022-05-25","kind":"sale","acquired":false,"shares":50000,"price":9.06,"value":453000.0,"ownership":{"direct":true},"balance_after":1306458,"source":{"system":"sec-edgar","filing":"0001731122-22-001013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222001013/ownership.xml","form_type":"4"}},{"id":2252955,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-28T00:30:22.000Z","date":"2022-05-25","kind":"exercise","acquired":true,"shares":50000,"price":0.92,"value":46000.0,"ownership":{"direct":true},"balance_after":1356458,"source":{"system":"sec-edgar","filing":"0001731122-22-001013","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222001013/ownership.xml","form_type":"4"}},{"id":2614484,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-08-04T21:22:28.000Z","date":"2021-08-02","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25000,"derivative":{"exercise_price":18.11,"exercise_date":"2022-08-02","expiration_date":"2031-08-02","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001731122-21-001294","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221001294/ownership.xml","form_type":"4"}},{"id":2925168,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-04T19:29:54.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":35000,"derivative":{"exercise_price":5.49,"exercise_date":"2021-12-30","expiration_date":"2030-12-30","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001731122-21-000016","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221000016/ownership.xml","form_type":"4"}},{"id":3315104,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-08T23:00:12.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":50000,"derivative":{"exercise_price":2.96,"exercise_date":"2021-01-06","expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001731122-20-000018","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000173112220000018/ownership.xml","form_type":"4"}},{"id":3794138,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-09T20:42:31.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options shall vest upon the achievement of 50% enrollment in the Company's Alzheimer's disease and Parkinson's disease dementia clinical trials."}],"balance_after":45500,"derivative":{"exercise_price":2.58,"expiration_date":"2028-10-01","underlying":"Common Stock","underlying_shares":45500},"source":{"system":"sec-edgar","filing":"0001615774-18-010620","document":"s113196_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000161577418010620/s113196_form4.xml","form_type":"4"}},{"id":4594970,"issuer":{"id":6086,"kind":"organization","name":"ANAVEX LIFE SCIENCES CORP.","symbol":"AVXL"},"owners":[{"id":81212,"kind":"person","name":"Skarpelos Athanasios","position":1,"cik":"0001360570","reported_name":"Skarpelos Athanasios","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-26T21:23:19.000Z","date":"2016-09-22","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":100000,"derivative":{"exercise_price":3.28,"exercise_date":"2016-09-22","expiration_date":"2026-09-22","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001615774-16-007388","document":"s104218_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1314052/000161577416007388/s104218_form4.xml","form_type":"4"}}]}